Organ Engineer Cleared of Some Misconduct Charges

An investigation has found the thoracic surgeon who transplanted artificial tracheae into patients not guilty of overhyping his research.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

An artificial trachea, similar to those transplanted by Macchiarini, made by seeding an inorganic scaffold with stem cellsUCLThe thoracic surgeon whose work creating and implanting artificial windpipes was questioned by colleagues last year has been cleared in the first of two internal investigations into his research and publication practices. Paolo Macchiarini, a visiting professor at the Karolinska Institute in Stockholm, fielded complaints from a colleague, head and neck surgeon Pierre Delaere of UZ Leuven in Belgium, which alleged that Macchiarini purposefully trumped up claims of success in several papers he published in The Lancet and engaged in data fabrication. Those accusations, first mentioned to Karolinska administrators in 2011, sparked an internal investigation after Delaere lodged a formal complaint last June. But on Tuesday (April 14), Karolinska officials announced that the institute’s ethics council found Macchiarini not guilty of those charges. “We find that the issues raised by Professor Delaere are of a philosophy-of-science kind rather than of a research-ethical kind,” the council said in a statement posted by Retraction Watch. “Professor Delaere’s allegations of scientific misconduct are unfounded.”

“We all felt terrible [about the investigation] because it affected our credibility, the credibility of my team,” Macchiarini told Science. “We are now happy that everything has been cleared.” The surgeon, who has maintained his innocence since the allegations went public, echoed the council’s findings. “As I have emphatically stated all along that the allegations from Dr. Delaere are unfounded,” he told Retraction Watch, “I am pleased that the Ethics Council has now also affirmed their lack of substance.”

Delaere told Science that he's disappointed with the conclusion reached by the ethics council, saying that he is “stunned about such outright injustice.”

Macchiarini still faces an accusation—levied last year by researchers at the Karolinska University Hospital—that he failed to obtain proper informed consent from patients ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform